A potentially functional polymorphism in the promoter region of let-7 family is associated with survival of hepatocellular carcinoma

Cancer Epidemiology

Volumn 37, Issue 6, 2013, Pages 998-1002

  Xie, Kaipeng ^a   Liu, Jibin ^b   Zhu, Liguo ^c   Liu, Yao ^a   Pan, Yun ^a   Wen, Juan ^a   Ma, Hongxia ^a   Zhai, Xiangjun ^c   Hu, Zhibin ^a,d  

^a Nanjing Medical University   (China)

^b NANTONG TUMOR HOSPITAL   (China)

^c JIANGSU PROVINCIAL CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^d NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Hepatocellular carcinoma; Let 7; Survival

Indexed keywords

ADULT; ARTICLE; CANCER PROGNOSIS; CHINESE; CLINICAL FEATURE; FEMALE; GENETIC ANALYSIS; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM;

HEPATOCELLULAR CARCINOMA; LET-7; SURVIVAL;

CARCINOMA, HEPATOCELLULAR; DNA, NEOPLASM; FEMALE; FOLLOW-UP STUDIES; HUMANS; LIVER NEOPLASMS; MALE; MICRORNAS; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; PROMOTER REGIONS, GENETIC; SURVIVAL RATE;

EID: 84888297249     PISSN: 18777821     EISSN: 1877783X     Source Type: Journal    
DOI: 10.1016/j.canep.2013.09.005     Document Type: Article

References (38)

1. Yang J.D., Roberts L.R. Hepatocellular carcinoma: a global view. Nat Rev Gastroenterol Hepatol 2010, 7(8):448-458.
2. Siegel R., Naishadham D., Jemal A. Cancer statistics. CA: Cancer J Clin 2013, 63(1):11-30.
3. Filipowicz W., Bhattacharyya S.N., Sonenberg N. Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?. Nat Rev Genet 2008, 9(2):102-114.
4. Gramantieri L., Fornari F., Callegari E., Sabbioni S., Lanza G., Croce C.M., et al. MicroRNA involvement in hepatocellular carcinoma. J Cell Mol Med 2008, 12(6a):2189-2204.
5. Mott J.L. MicroRNAs involved in tumor suppressor and oncogene pathways: implications for hepatobiliary neoplasia. Hepatology 2009, 50(2):630-637.
6. Reinhart B.J., Slack F.J., Basson M., Pasquinelli A.E., Bettinger J.C., Rougvie A.E., et al. The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature 2000, 403(6772):901-906.
7. Boyerinas B., Park S.M., Hau A., Murmann A.E., Peter M.E. The role of let-7 in cell differentiation and cancer. Endocrine-Related Cancer 2010, 17(1):F19-F36.
8. Roush S., Slack F.J. The let-7 family of microRNAs. Trends Cell Biol 2008, 18(10):505-516.
9. Wang X., Cao L., Wang Y., Liu N., You Y. Regulation of let-7 and its target oncogenes (Review). Oncol Lett 2012, 3(5):955-960.
10. Sugimura K., Miyata H., Tanaka K., Hamano R., Takahashi T., Kurokawa Y., et al. Let-7 expression is a significant determinant of response to chemotherapy through the regulation of IL-6/STAT3 pathway in esophageal squamous cell carcinoma. Clin Cancer Res 2012, 18(18):5144-5153.
11. Shell S., Park S.-M., Radjabi A.R., Schickel R., Kistner E.O., Jewell D.A., et al. Let-7 expression defines two differentiation stages of cancer. Proc Natl Acad Sci USA 2007, 104(27):11400-11405.
12. Sampson V.B., Rong N.H., Han J., Yang Q., Aris V., Soteropoulos P., et al. MicroRNA let-7a down-regulates MYC and reverts MYC-induced growth in Burkitt lymphoma cells. Cancer Res 2007, 67(20):9762-9770.
13. Lee Y.S., Dutta A. The tumor suppressor microRNA let-7 represses the HMGA2 oncogene. Genes Dev 2007, 21(9):1025-1030.
14. Johnson S.M., Grosshans H., Shingara J., Byrom M., Jarvis R., Cheng A., et al. RAS is regulated by the let-7 microRNA family. Cell 2005, 120(5):635-647.
15. Lan F.F., Wang H., Chen Y.C., Chan C.Y., Ng S.S., Li K., et al. Hsa-let-7g inhibits proliferation of hepatocellular carcinoma cells by downregulation of c-Myc and upregulation of p16(INK4A). Int J Cancer 2011, 128(2):319-331.
16. Wang Y.C., Chen Y.L., Yuan R.H., Pan H.W., Yang W.C., Hsu H.C., et al. Lin-28B expression promotes transformation and invasion in human hepatocellular carcinoma. Carcinogenesis 2010, 31(9):1516-1522.
17. Zhu X.M., Wu L.J., Xu J., Yang R., Wu F.S. Let-7c microRNA expression and clinical significance in hepatocellular carcinoma. J Int Med Res 2011, 39(6):2323-2329.
18. Hu Z., Chen J., Tian T., Zhou X., Gu H., Xu L., et al. Genetic variants of miRNA sequences and non-small cell lung cancer survival. J Clin Investig 2008, 118(7):2600.
19. Hu Z., Shu Y., Chen Y., Chen J., Dong J., Liu Y., et al. Genetic polymorphisms in the precursor microRNA flanking region and non-small cell lung cancer survival. Am J Respir Crit Care Med 2011, 183(5):641-648.
20. Xu Y., Liu L., Liu J., Zhang Y., Zhu J., Chen J., et al. A potentially functional polymorphism in the promoter region of miR-34b/c is associated with an increased risk for primary hepatocellular carcinoma. Int J Cancer 2011, 128(2):412-417.
21. Liu Y., Zhang Y., Wen J., Liu L., Zhai X., Liu J., et al. A genetic variant in the promoter region of miR-106b-25 cluster and risk of HBV infection and hepatocellular carcinoma. PLoS ONE 2012, 7(2):e32230.
22. Huang F., Hu L.M., Liu J.B., Zhang Y.X., Hu Z.B. Relationship between genetic polymorphism of promoter region let-7 and genetic susceptibility to hepatocellular carcinoma. Zhonghua yu fang yi xue za zhi [Chin J Prev Med] 2011, 45(12):1093-1098.
23. Hu L., Zhai X., Liu J., Chu M., Pan S., Jiang J., et al. Genetic variants in human leukocyte antigen/DP-DQ influence both hepatitis B virus clearance and hepatocellular carcinoma development. Hepatology 2012, 55(5):1426-1431.
24. Forner A., Llovet J.M., Bruix J. Hepatocellular carcinoma. Lancet 2012, 379(9822):1245-1255.
25. Heintzman N.D., Stuart R.K., Hon G., Fu Y., Ching C.W., Hawkins R.D., et al. Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome. Nat Genet 2007, 39(3):311-318.
26. Takamizawa J., Konishi H., Yanagisawa K., Tomida S., Osada H., Endoh H., et al. Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res 2004, 64(11):3753-3756.
27. Wang S., Tang Y., Cui H., Zhao X., Luo X., Pan W., et al. Let-7/miR-98 regulate Fas and Fas-mediated apoptosis. Genes Immun 2011, 12(2):149-154. [Epub 14.01.11].
28. Jiang Y., Qin Z., Hu Z., Guan X., Wang Y., He Y., et al. Genetic variation in a hsa-let-7 binding site in RAD52 is associated with breast cancer susceptibility. Carcinogenesis 2013, 34(3):689-693.
29. Ryan B.M., Robles A.I., Harris C.C. KRAS-LCS6 genotype as a prognostic marker in early-stage CRC-letter. Clin Cancer Res 2012, 18(12):3487-3488.
30. Smits K.M., Paranjape T., Nallur S., Wouters K.A., Weijenberg M.P., Schouten L.J., et al. A let-7 microRNA SNP in the KRAS 3'UTR is prognostic in early-stage colorectal cancer. Clin Cancer Res 2011, 17(24):7723-7731.
31. Chen A.X., Yu K.D., Fan L., Li J.Y., Yang C., Huang A.J., et al. Germline genetic variants disturbing the Let-7/LIN28 double-negative feedback loop alter breast cancer susceptibility. PLoS Genet 2011, 7(9):e1002259.
32. Christensen B.C., Moyer B.J., Avissar M., Ouellet L.G., Plaza S.L., McClean M.D., et al. A let-7 microRNA-binding site polymorphism in the KRAS 3'UTR is associated with reduced survival in oral cancers. Carcinogenesis 2009, 30(6):1003-1007.
33. Mudduluru G., Vajkoczy P., Allgayer H. Myeloid zinc finger 1 induces migration, invasion, and in vivo metastasis through Axl gene expression in solid cancer. Mol Cancer Res 2010, 8(2):159-169.
34. Kroger A., Koster M., Schroeder K., Hauser H., Mueller P.P. Activities of IRF-1. J Interferon Cytokine Res 2002, 22(1):5-14.
35. Boyle A.P., Hong E.L., Hariharan M., Cheng Y., Schaub M.A., Kasowski M., et al. Annotation of functional variation in personal genomes using RegulomeDB. Genome Res 2012, 22(9):1790-1797.
36. Shan C., Zhang S., Cui W., You X., Kong G., Du Y., et al. Hepatitis B virus X protein activates CD59 involving DNA binding and let-7i in protection of hepatoma and hepatic cells from complement attack. Carcinogenesis 2011, 32(8):1190-1197.
37. Yang N., Kaur S., Volinia S., Greshock J., Lassus H., Hasegawa K., et al. MicroRNA microarray identifies Let-7i as a novel biomarker and therapeutic target in human epithelial ovarian cancer. Cancer Res 2008, 68(24):10307-10314.
38. Blower P.E., Chung J.H., Verducci J.S., Lin S., Park J.K., Dai Z., et al. MicroRNAs modulate the chemosensitivity of tumor cells. Mol Cancer Ther 2008, 7(1):1-9.